Traditional analysis
Carnegie, Erik Hultgård, +46 8 588 687 43

Commissioned analysis

Erik Penser Bank, Sweden, Klas Palin
+46 (0)73 261 82 60
Read initiating report

Redeye, Sweden, Ethel Luvall 
+46 (0)76 492 50 95
Read the latest Report

Orexo has decided to terminate the contract with Redeye, which will be effective as of December 21, 2022

RX Securities, London, UK, Dr Samir Devani
+44 (0)20 7993 8210
E-mail: info@rxsecurities.com
The report is only available for institutional investors